| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13668-676-01 | 13668-676 | HUMAN PRESCRIPTION DRUG | Dichlorphenamide | Dichlorphenamide | TABLET | ORAL | 20221229 | N/A | ANDA | ANDA215924 | Torrent pharmaceuticals limited | DICHLORPHENAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (13668-676-01) |
| 13668-676-30 | 13668-676 | HUMAN PRESCRIPTION DRUG | Dichlorphenamide | Dichlorphenamide | TABLET | ORAL | 20221229 | N/A | ANDA | ANDA215924 | Torrent pharmaceuticals limited | DICHLORPHENAMIDE | 50 mg/1 | 30 TABLET in 1 BOTTLE (13668-676-30) |
| 70709-085-10 | 70709-085 | HUMAN PRESCRIPTION DRUG | ORMALVI | Dichlorphenamide | TABLET | ORAL | 20240315 | N/A | ANDA | ANDA215924 | Cycle Pharmaceuticals Ltd. | DICHLORPHENAMIDE | 50 mg/1 | 100 TABLET in 1 BOTTLE (70709-085-10) |